![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
HIV Infection |
Free Subscription
6 AIDS |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO HIV Infection is free of charge.
Surrogate neutralisation responses following SARS-CoV-2 vaccination in people
living with HIV - comparison between inactivated and mRNA vaccine.
AIDS. 2022 Apr 23. pii: 00002030-990000000-00010.
PubMed
Abstract available
The cost-effectiveness of a resilience-based psychosocial intervention for HIV
prevention among men who have sex with men in India.
AIDS. 2022 Apr 26. pii: 00002030-990000000-00012.
PubMed
Abstract available
Risk of subarachnoid haemorrhages and aneurysms in Danish People Living With HIV,
a nationwide cohort study.
AIDS. 2022 Apr 27. pii: 00002030-990000000-00014.
PubMed
Abstract available
Abnormal cognitive aging in people with HIV: Evidence from Data Integration
between two countries' cohort studies.
AIDS. 2022 Apr 27. pii: 00002030-990000000-00013.
PubMed
Abstract available
High Efficacy of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in
People with Suppressed HIV and Preexisting M184 V/I.
AIDS. 2022 Apr 23. pii: 00002030-990000000-00011.
PubMed
Abstract available
Significance of lymph node fine needle aspiration for the diagnosis of
HIV-associated lymphoma in a low-resource setting.
AIDS. 2022 Apr 23. pii: 00002030-990000000-00009.
PubMed
Abstract available
Quality of life and antiretroviral therapy adherence: A cross-sectional study in
Colombia.
AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2021.0233.
PubMed
Abstract available
Contribution of Innate Lymphoid Cells in Supplementing Cytokines Produced by CD4+
T-cells During Acute and Chronic SIV Infection of the Colon.
AIDS Res Hum Retroviruses. 2022 Apr 22. doi: 10.1089/AID.2022.0007.
PubMed
Abstract available
Long-term safety and efficacy of rilpivirine in combination with
nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected
patients: 336-week rollover study of phase 2b and 3 clinical studies.
Antivir Ther. 2021;26.
PubMed
Abstract available
HBV co-infection is associated with persistently elevated liver stiffness
measurement in HIV-positive adults: A 6-year single-centre cohort study in
Nigeria.
Antivir Ther. 2021;26.
PubMed
Abstract available
Comparison of three galenic forms of lamivudine in young West African children
living with Human Immunodeficiency Virus.
Antivir Ther. 2021;26.
PubMed
Abstract available
Rilpivirine plus cobicistat-boosted darunavir as alternative to standard
three-drug therapy in HIV-infected, virologically suppressed subjects: Final
results of the PROBE 2 trial.
Antivir Ther. 2021;26.
PubMed
Abstract available
Low prevalence of doravirine-associated resistance mutations among polish human
immunodeficiency-1 (HIV-1)-infected patients.
Antivir Ther. 2021;26.
PubMed
Abstract available
Evaluation of doravirine-based regimen population target in a large Italian
clinical center.
Antivir Ther. 2021;26.
PubMed
Abstract available
Real-life findings on the impact of the COVID-19 pandemic on HIV care.
Antivir Ther. 2021;26.
PubMed
Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa
is observed at lower CD4(+) cell counts.
Antivir Ther. 2021;26.
PubMed
Abstract available
Outcomes of patients presenting with Guillain-Barre Syndrome at a tertiary care
center in India.
BMC Neurol. 2022;22:151.
PubMed
Abstract available
Circular RNA vaccines against SARS-CoV-2 and emerging variants.
Cell. 2022 Apr 1. pii: S0092-8674(22)00394-4. doi: 10.1016/j.cell.2022.
PubMed
Abstract available
Characterizing HIV-preventive, plasma tenofovir concentrations. A pooled
participant-level data analysis from HIV pre-exposure prophylaxis (PrEP) clinical
trials.
Clin Infect Dis. 2022 Apr 26. pii: 6574602. doi: 10.1093.
PubMed
Abstract available
Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis
Treatment Outcomes: An Individual Participant Data Meta-Analysis.
Clin Infect Dis. 2022 Apr 27. pii: 6574751. doi: 10.1093.
PubMed
Abstract available
Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort
Study as an Epidemiologically Distinct Risk Group.
Clin Infect Dis. 2022 Apr 27. pii: 6575499. doi: 10.1093.
PubMed
Sexually transmitted infections in pregnant people living with HIV: Temporal
trends, demographic correlates and association with preterm birth.
Clin Infect Dis. 2022 Apr 29. pii: 6576157. doi: 10.1093.
PubMed
Abstract available
The Impact of Vitamin A Deficiency on Tuberculosis Progression.
Clin Infect Dis. 2022 Apr 29. pii: 6576158. doi: 10.1093.
PubMed
Abstract available
Reimagining Preexposure Prophylaxis Provision for Women in the United States.
Clin Infect Dis. 2022 Apr 28. pii: 6432205. doi: 10.1093.
PubMed
Abstract available
Prevalence, progression, and management of advanced chronic kidney disease in a
cohort of people living with HIV.
HIV Med. 2022 Apr 26. doi: 10.1111/hiv.13317.
PubMed
Abstract available
Quantification of CD4 Recovery in Early-Treated Infants Living With HIV.
J Acquir Immune Defic Syndr. 2022;89:546-557.
PubMed
Abstract available
Previous Pre-Exposure Prophylaxis Use Among Men Who Have Sex with Men Newly
Diagnosed with HIV Infection in King County, Washington.
J Acquir Immune Defic Syndr. 2022 Apr 29. pii: 00126334-990000000-00035.
PubMed
Abstract available
Effect of HIV Serostatus on ICU Admission and Mortality among Hospitalized
Coronavirus Disease 2019 (COVID-19) Patients.
J Acquir Immune Defic Syndr. 2022 Apr 28. pii: 00126334-990000000-00031.
PubMed
Plasma Cell-Free Mitochondrial DNA as a Marker of Geriatric Syndromes in Older
Adults with HIV.
J Acquir Immune Defic Syndr. 2022 Apr 26. pii: 00126334-990000000-00029.
PubMed
Abstract available
Targeted implementation of HIV self-testing increases testing uptake among
partners of index persons known to have HIV in Kenya.
J Acquir Immune Defic Syndr. 2022 Apr 27. pii: 00126334-990000000-00030.
PubMed
Abstract available
A systematic molecular epidemiology screen reveals numerous HIV-1 superinfections
in the Swiss HIV Cohort Study.
J Infect Dis. 2022 Apr 29. pii: 6575836. doi: 10.1093.
PubMed
Abstract available
Machine learning quantifies accelerated white-matter aging in persons with HIV.
J Infect Dis. 2022 Apr 28. pii: 6575226. doi: 10.1093.
PubMed
Abstract available
T cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the
third booster dose of an inactivated vaccine.
J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27814.
PubMed
Abstract available
IKKalpha-Mediated Noncanonical NF-kappaB Signaling Is Required To Support Murine
Gammaherpesvirus 68 Latency In Vivo.
J Virol. 2022 Apr 28:e0002722. doi: 10.1128/jvi.00027.
PubMed
Abstract available
Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically
Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.
J Virol. 2022 Apr 27:e0043222. doi: 10.1128/jvi.00432.
PubMed
Abstract available
Phylogenetic analysis of migration, differentiation, and class switching in B
cells.
PLoS Comput Biol. 2022;18:e1009885.
PubMed
Abstract available
Antithetic effect of interferon-alpha on cell-free and cell-to-cell HIV-1
infection.
PLoS Comput Biol. 2022;18:e1010053.
PubMed
Abstract available
Nucleic acid testing identifies high prevalence of blood borne viruses among
approved blood donors in Mozambique.
PLoS One. 2022;17:e0267472.
PubMed
Abstract available
Novel assays to investigate the mechanisms of latent infection with HIV-2.
PLoS One. 2022;17:e0267402.
PubMed
Abstract available
A combination of potently neutralizing monoclonal antibodies isolated from an
Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
PLoS Pathog. 2022;18:e1010465.
PubMed
Abstract available
War, pandemic and vaccination - Upcoming health problems by the refugee wave in
Europe?
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00465.
PubMed
Construction and characterization of a full-length, replication-competent and
infectious enhanced green fluorescence protein-tagged HIV-1 subtype C molecular
clone.
Virology. 2022;571:34-38.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by